191 related articles for article (PubMed ID: 28987830)
1. Intracranial Meningioma in Patients Age <35 Years: Evolution of the Disease in the Era of Human Immunodeficiency Virus Infection.
Motebejane MS; Kaminsky I; Choi IS
World Neurosurg; 2018 Jan; 109():e292-e297. PubMed ID: 28987830
[TBL] [Abstract][Full Text] [Related]
2. WHO grade of intracranial meningiomas differs with respect to patient's age, location, tumor size and peritumoral edema.
Ressel A; Fichte S; Brodhun M; Rosahl SK; Gerlach R
J Neurooncol; 2019 Nov; 145(2):277-286. PubMed ID: 31578671
[TBL] [Abstract][Full Text] [Related]
3. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
4. Demographic profile of patients diagnosed with intracranial meningiomas in two academic hospitals in Johannesburg, South Africa: a 12-month prospective study.
Ibebuike K; Ouma J
Afr Health Sci; 2014 Dec; 14(4):939-45. PubMed ID: 25834505
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
van de Nes JA; Griewank KG; Schmid KW; Grabellus F
Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
[TBL] [Abstract][Full Text] [Related]
6. Application of arterial spin labeling perfusion MRI to differentiate benign from malignant intracranial meningiomas.
Qiao XJ; Kim HG; Wang DJJ; Salamon N; Linetsky M; Sepahdari A; Ellingson BM; Pope WB
Eur J Radiol; 2017 Dec; 97():31-36. PubMed ID: 29153364
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for High-Grade Meningioma in Brain and Spine: Systematic Review and Meta-analysis.
Shin HK; Park JH; Cho YH; Kim YH; Hong SH; Kim JH; Roh SW; Jeon SR
World Neurosurg; 2021 Jul; 151():e718-e730. PubMed ID: 33974984
[TBL] [Abstract][Full Text] [Related]
8. Pathodiagnostic parameters and evaluation of O⁶- methyl guanine methyl transferase gene promoter methylation in meningiomas.
Jabini R; Moradi A; Afsharnezhad S; Ayatollahi H; Behravan J; Raziee HR; Mosaffa F
Gene; 2014 Apr; 538(2):348-53. PubMed ID: 24398011
[TBL] [Abstract][Full Text] [Related]
9. Correlation between magnetic resonance imaging grading and pathological grading in meningioma.
Lin BJ; Chou KN; Kao HW; Lin C; Tsai WC; Feng SW; Lee MS; Hueng DY
J Neurosurg; 2014 Nov; 121(5):1201-8. PubMed ID: 25148010
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and treatment of World Health Organization grade II and III meningiomas in childhood: report of 23 cases.
Wang XQ; Jiang CC; Zhao L; Gong Y; Hu J; Chen H
J Neurosurg Pediatr; 2012 Nov; 10(5):423-33. PubMed ID: 22938082
[TBL] [Abstract][Full Text] [Related]
12. Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis.
Spille DC; Heß K; Sauerland C; Sanai N; Stummer W; Paulus W; Brokinkel B
World Neurosurg; 2016 Sep; 93():346-54. PubMed ID: 27344043
[TBL] [Abstract][Full Text] [Related]
13. Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases.
Cornelius JF; Slotty PJ; Steiger HJ; Hänggi D; Polivka M; George B
Acta Neurochir (Wien); 2013 Mar; 155(3):407-13. PubMed ID: 23318687
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing grade I meningioma from higher grade meningiomas without biopsy.
Varlotto J; Flickinger J; Pavelic MT; Specht CS; Sheehan JM; Timek DT; Glantz MJ; Sogge S; Dimaio C; Moser R; Yunus S; Fitzgerald TJ; Upadhyay U; Rava P; Tangel M; Yao A; Kanekar S
Oncotarget; 2015 Nov; 6(35):38421-8. PubMed ID: 26472106
[TBL] [Abstract][Full Text] [Related]
15. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
[TBL] [Abstract][Full Text] [Related]
16. Surgical outcome in elderly patients with intracranial meningioma.
Amano T; Nakamizo A; Michiwaki Y; Matsuo S; Fujioka Y; Nagata S
J Clin Neurosci; 2018 Oct; 56():63-66. PubMed ID: 30031568
[TBL] [Abstract][Full Text] [Related]
17. The accuracy of meningioma grading: a 10-year retrospective audit.
Willis J; Smith C; Ironside JW; Erridge S; Whittle IR; Everington D
Neuropathol Appl Neurobiol; 2005 Apr; 31(2):141-9. PubMed ID: 15771707
[TBL] [Abstract][Full Text] [Related]
18. Grade 2 meningioma and radiosurgery.
Aboukais R; Zairi F; Lejeune JP; Le Rhun E; Vermandel M; Blond S; Devos P; Reyns N
J Neurosurg; 2015 May; 122(5):1157-62. PubMed ID: 25748308
[TBL] [Abstract][Full Text] [Related]
19. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
[TBL] [Abstract][Full Text] [Related]
20. Pathodiagnostic parameters for meningioma grading.
Moradi A; Semnani V; Djam H; Tajodini A; Zali AR; Ghaemi K; Nikzad N; Madani-Civi M
J Clin Neurosci; 2008 Dec; 15(12):1370-5. PubMed ID: 18819804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
